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Abstract
Background: Oleuropein (OL) is a well-known anti-oxidative agent and is shown to reduce the hypoxia-inducible
factor 1 α (HIF1α) protein expression after radiation. The current study investigated the effects of OL on radiation
response in nasopharyngeal carcinoma (NPC).
Methods: Colony formation assay was performed to compare the radiation response in vitro. Xenograft mouse
model was used to study the OL effects on radiation in vivo. Chromatin immunoprecipitation and luciferase reporter
assays were performed to identify the relations among HIF1α, miR-519d and PDRG1. Stable HIF1α or PDRG1
overexpression, and miR-519d downregulation were performed to test the radiation response both in vitro and in vivo.
Results: OL strongly enhanced radiosensitivity of NPC cells both in vitro and in vivo. Chromatin immunoprecipitation
and luciferase reporter assays suggested miR-519d was a direct target of HIF1α, and PDRG1 was a direct target
of miR-519d. Overexpression of HIF1α or PDRG1, and downregulation of miR-519d abolished the radiation
sensitizing effects of OL.
Conclusion: Our study hereby demonstrates OL is a radiation sensitizing agent in NPC both in vivo and in vitro.
OL treatment reduces the activity of HIF1α-miR-519d-PDRG1 pathway, which is essential to the radiosensitizing
effects of OL.
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Background
Nasopharyngeal carcinoma (NPC) has a widely unbal-
anced endemic distribution, with the highest incidence
reported in Southeast Asia [1]. Due to its anatomical
location and relatively sensitivity to irradiation, radio-
therapy is the primary treatment option for NPC pa-
tients without metastasis, although the clinical outcome
of NPC has been hindered by resistance to radiotherapy.
Thus, understanding the underlying mechanism of radi-
ation resistance and developing the radiosensitive drugs
are urgent needs for improving the local control and
survival rate of advanced NPC patients.
Oleuropein (OL) is the main component of olive leaf
extract, and is a well-established anti-oxidative agent [2].
Recently, OL has been extensively reported as a potential
anti-cancer reagent by many researchers [3]. A recently
study showed OL could reduce the protein expression of
hypoxia-inducible factor 1 α (HIF1α) [4], which is a
major regulator of the radiation response in cancer
cells. Thus it is of great interest to investigate whether
OL could exhibit a potential radiosensitizing effect on
cancer cells.
MicroRNA (miRNA or miR) is a class of endogenous,
20–22 nucleotides in length, non-coding RNAs. MiRNAs
can recognize and bind to the 3′ untranslated regions
(UTRs) of their target mRNAs to suppress their transla-
tion or. There are many evidences suggesting miRNAs are
involved in radiation response [5]. Kraemer et al. found
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that knockdown of either DICER or AGO2 sensitized
endothelial cells to radiation [6]. In addition, overexpres-
sions of miR-100 and miR-101 [7, 8] were found to
sensitize tumors to radiation, whereas overexpressions of
miR-17-92 and miR-155 [9, 10] protected tumor cells
from radiation damage. Studies are needed to investigate
if agents such as OL could exert its radiosensitizing effect
through regulating miRNA expressions.
In our current study, we investigated the effects of OL
on the regulation of radiation response in NPC cells
both in vitro and in vivo. The potential underlying
mechanism involving miRNA was studied as well.
Methods
Cell culture and transfection
The human NPC cell lines HNE1 and HONE1 were pur-
chased from the Cancer Research Institute of Central
South University, China. To generate HIF1α or PDRG1
overexpression cells, a lentivirus based stable overex-
pression system (Naldini and Trono, La Jolla, CA, USA)
was used. Briefly, 293 T cells were co-transfected with
either pCDH-EF1-MCS empty vector or pCDH-EF1-
MCS-HIF1α/pCDH-EF1-MCS- PDRG1 with pVSV-G
and pCMV-deltaR8.2 to make pseudoviral particles
according to the manufacturer’s directions. HNE1 and
HONE1 cells were then infected with lentivirus for
48 h, followed by one week selection in RPMI-1640
medium containing 2 μg/ml puromycin, 10% fetal bovine
serum, 1% penicillin and streptomycin at 37 °C under 5%
CO2.
Clonogenic assays
To investigate the radiation effect in vitro, 1,000 cells/
well were seeded onto 6-well plate and then radiated
with different doses (0, 5 and 10 Gy) with a 210 kV X-
ray source at 2 Gy/min. After incubated in RPMI-1640
medium with or without 200 μM OL treatment at 37 °C,
5% CO2 for 10 days, cells were fixed and stained with
0.5% crystal violet in 20% methanol. Colony numbers
were counted, and plating efficiency and survival
fraction were calculated afterwards. Survival fraction
curves were determined with a linear-quadratic model
[S = exp (-αD-βD2)] using GraphPad Prism 4.0
(GraphPad Prism, San Diego, CA, USA).
Western blot
Cell lysates were prepared using ice-cold lysis buffer
(Tris–HCl pH 7.8 20 mM, NaCl 137 mM, EDTA
pH 8.0 2 mM, NP40 1% and protease inhibitor cock-
tail) and separated by SDS-PAGE gel. Blots were incu-
bated with anti-HIF1α, anti-PDRG1 or anti-GAPDH
antibody overnight following the antibody instructions.
Anti-HIF1α, anti-PDRG1 antibodies were purchased
from Cell Signaling Technology (Danvers, MA, USA);
anti-GAPDH antibody was purchased from Santa-Cruz
Biotechnology (Santa Cruz, CA, USA). Bands were
visualized using Pierce ECL Substrate (Thermo
Scientific, Waltham, MA, USA).
Quantitative real-time PCR
Total RNA was obtained using TRIzol (Invitrogen,
Carlsbad, CA, USA). The cDNA was synthesized using a
SuperScript RT-PCR kit (Invitrogen, Carlsbad, CA, USA).
The primers used in the current study included: HIF1α
forward 5′-CTC AAA GTC GGA CAG CCT CA-3′, rev
erse 5′-CCC TGC AGT AGG TTT CTG CT-3′; PDRG1
forward 5′-GAC CTG GAC ACC AAG AGG AA-3′, rev
erse 5′-GGT GCT CCT GAT CTT TCT GG-3′; miR-5
19d 5′-ACA CTC CAG CTG GGC AAA GTG CCT
CCC T-3′, and 5′-CTC AAC TGG TGT CGT GGA-3′;
GAPDH forward 5′- TGC ACC ACC AAC TGC TTA
GC-3′, reverse 5′- GGC ATG GAC TGT GGT CAT
GAG-3′. All expressions were normalized to GAPDH
messenger level.
Dual-luciferase reporter assay
Wild type or mutated 3′-UTR of PDRG1 mRNA were
clone to the downstream of the luciferase reporter open
reading frame, and the promoter region of miR-519d
containing two HRE (HRE-wt) or the mutated version
(HRE-mut) were cloned to the upstream promoter re-
gion of pGL3-enhancer plasmid using the pMir-Report
vector kit (Applied Biosystems, Carlsbad, CA, USA).
105/well cells transduced with indicated plasmid were
seeded in 24 well plate and transfected with indicated
luciferase constructs by Lipofectamine 2000 (Invitrogen,
Carlsbad, CA, USA). Cells were allowed to grow 24 h after
the transfection. The luciferase activities were determined
with a dual-luciferase reporter assay kit (Promega, Madison,
WI, USA) according to the instructions.
Chromatin immunoprecipitation (ChIP) assay
Cells were cross-linked with 1% formaldehyde and sub-
sequently immunoprecipitated with antibodies against
HIF1α (Cell Signaling, Danvers, MA, USA). The PCR
primers were designed to amplify the promoter regions
containing HRE within miR-519d promoter region. A
negative control with IgG was used. Fold enrichment
was calculated as a ratio of amplification efficiency of
the ChIP sample over that of IgG.
MicroRNA microarray assay
Total RNA was extracted using Trizol (Qiagen, Valencia,
CA, USA). Microarray assay was performed with the
μParaflo™ MicroRNA microarray assay system (LC
Sciences, Houston, TX, USA) according to the instruction.
The images were collected using GenePix 4000B,
Molecular Device and were analyzed using the Array-Pro
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image analysis software (Media Cybernetics, Rockville,
MD, USA). The differences between signals with p < 0.05
were subjected to analysis and then were displayed in a
heat-map using Java TreeView 1.0.13.
MicroRNA assays
Stable cell lines expressing miR-519d inhibitor were
made using the MISSION Lenti miR-519d Inhibitor kit
(Sigma-Aldrich, St. Louis, MO, USA) according to man-
ufacturer’s instructions. Expression efficiency of miR-
519d-3p was determined using a mature miRNA assay kit
(478986_mir, Applied Biosystems, Carlsbad, CA, USA).
Xenograft model
106 /100 μl indicated tumor cells were injected to 6–8
weeks old BALB/C nude mice purchased from the
Shanghai Experimental Animal Center (Shanghai, China)
subcutaneously, 10 mice for each group. Tumor-injection
mice were allowed to grow 7 days without any treatment
to establish tumors. OL was added in drinking water at
the final concentration of 1% [3] starting from day 7 to
the end of the animal study (day 21). All mice received
12 Gy dosage of radiation at day 7 and 14, respectively,
with an X-ray generator, as illustrated in Fig. 1c. Each
mouse was covered with a lead cover allowing only tumor
parts to be radiated. Tumor volumes were measured along
three orthogonal axes (a, b, and c) and determined as
tumor volume = abc/2. This study was carried out in strict
accordance with the recommendations in the Guide for
the Care and Use of Laboratory Animals of the National
Institutes of Health. The protocol was approved by the
Committee on the Ethics of Animal Experiments of The
Second People’s Hospital of Wuxi. All surgery was per-
formed under sodium pentobarbital anesthesia, and all
efforts were made to minimize suffering.
Statistical analysis
Results are presented as means ± SD. Differences of
tumor growth curves were assessed by repeated-measure
ANOVA. Differences between two groups were analyzed
by student’s t-test. All statistics analyses were performed
using GraphPad Prism 6.0 or SAS 9.4 (SAS Institute
Inc., Cary, NC, USA). p < 0.05 was considered statisti-
cally significant. All statistical analysis was performed
using SPSS 17.0 (SPSS, Inc., Chicago, IL, USA).
Fig. 1 OL enhances radiosensitivity of NPC cells both in vitro and in vivo. a and b Viability of NPC cells HNE-1 (a) and HONE-1 (b) were assessed,
after incubation with media containing 0 or 200 μM of OL for 24 h, respectively, and then subjected to radiation dosage as indicated. c Experimental
time line of the xenograft mouse model, with cell injection performed on day 0 and irradiation (IR, 12 Gy) performed on both day 7 and 14. d and e
Growth curve of HNE-1 (d) and HONE-1 (e) xenograft tumors in mice after mock or OL treatment, respectively (n = 10 each). Values were expressed as
mean ± SD. * p < 0.05, ** p < 0.01, compared to 0 μM OL. # p < 0.05, compared to mock treatment
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Results
OL enhances radiosensitivity of NPC cells both in vitro
and in vivo
To investigate the effects of OL on radiation sensitivity,
we performed colony formation assay in NPC cell lines
HNE-1 and HONE-1 incubated with or without OL after
irradiation. As shown in Fig. 1a and b, 24 h of 200 μM
OL treatment significantly reduced the survival fractions
in both cell lines, suggesting OL increased the sensitivity
of these cells towards radiation. Furthermore, OL was
shown to reduce the tumor volumes after radiation in a
mouse xenograft model of NPC (Fig. 1c, d and e).
Together, our data suggested OL strongly enhanced
radiosensitivity of NPC cells both in vitro and in vivo.
OL alters expressions of miRNAs and genes in NPC
We then tried to characterize whether miRNA expres-
sion profile was altered by the OL treatment. We pro-
filed miRNA expressions after OL treatment (Fig. 2a),
and found that there were 22 miRNAs upregulated after
24 h of 200 μM OL treatment in both HNE-1 and
HONE-1 NPC cell lines. Since OL is a well-known anti-
oxidant [11], we hypothesized that OL treatment may
affect the expression of HIF1α through its anti-oxidative
properties. Indeed, both mRNA and protein levels of
HIF1α were decreased after OL treatment in both NPC
cell lines (Fig. 2b and d). Moreover, the expressions of
p53 and DNA damage-regulated protein (PDRG1) were
also reduced by OL treatment at both the mRNA and
protein levels (Fig. 2c and d), suggesting the genes
involved in DNA damage repair were repressed by OL
treatment.
MiR-519d directly targets the 3′-UTR of PDRG1 mRNA
To examine whether the OL-induced upregulation in
miRNA levels contributed to the decrease of PDRG1 ex-
pression, we performed an in silicon analysis using the
miRanda algorithm [12]. Interestingly, we have identified
that the 3′-UTR of PDRG1 possessed a potential binding
sequence of miR-519d, which was one of the 22 miRNAs
Fig. 2 OL altered expression of genes in NPC cells. a NPC cells HNE-1 and HONE-1 were incubated for 24 h with media containing 0 or 200 μM
of OL, respectively, and then subjected to microRNA array analysis. 22 miRNAs upregulated in both HNE-1 and HONE-1 cells were shown. b to c
mRNA levels of HIF1α (b), PDRG1 (c), as well as their protein levels (d) were analyzed in both HNE-1 and HONE-1 cells treated as in (a). Values were
expressed as mean ± SD. * p < 0.05, ** p < 0.01, compared to 0 μM OL
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found to be upregulated after OL treatment in both cell
lines (Fig. 3a). We then cloned the wild type or mutated
3′-UTR of PDRG1 mRNA into the downstream of a
luciferase reporter open reading frame (Fig. 3b), which
was subsequently transfected into cells stably express-
ing miR-NC or miR-519d, respectively. Cells were
allowed to grow 24 h after the transfection followed by
luciferase reporter assays. We found that overexpres-
sion of miR-519d significantly inhibited luciferase activ-
ity of wild type PDRG1 3′-UTR reporter, whereas
spared the mutated versions in both cell lines (Fig. 3c
and d). Furthermore, overexpression of miR-519d was
sufficient to reduce the expressions of both PDRG1
mRNA (Fig. 3e) and protein (Fig. 3f ) in the two NPC
cell lines.
MiR-519d upregulation by OL treatment is mediated by
HIF1α
Since OL was reported to reduce HIF1α expression [4],
we tried to investigate whether the process of OL-in-
duced miR-519d upregulation involves hypoxia and/or
HIF1α itself. We treated the cells with 100 μM CoCl2
for 24 h to induce HIF1α expression mimicking the hyp-
oxia condition. As shown in Fig. 4a, 24 h of 100 μM
CoCl2 treatment was sufficient to induce upregulation of
HIF1α protein. Moreover, miR-519d expressions were
decreased after CoCl2 treatment in both cell lines
(Fig. 4b). To confirm the effect of HIF1α on miR-519d
expression, stable HIF1α overexpression were
introduced in both cell lines using a lentivirus based
stable overexpression system (Fig. 4c and d). As shown
Fig. 3 miR-519d directly targets the 3′-UTR of PDRG1 mRNA. a Predicted miR-519d complementing sites on the 3′-UTR of PDRG1 mRNA. b Wild
type (PDRG1-wt) or mutated (PDRG1-mut) 3′-UTR sequences from PDRG1 mRNA were cloned at the downstream of a luciferase reporter gene
open reading frame (Luc ORF). c and d The above luciferase constructs were then transfected into NPC cells HNE-1 (c) and HONE-1 (d) expressing
either negative control miR (miR-NC) or miR-519d, respectively. 24 h after transfection, luciferase activities of PDRG1-wt or PDRG1-mut constructs
were measured. e and f PDRG1 mRNA (e) and protein (f) levels were analyzed in cells treated as in (c). Values were expressed as mean
± SD. ** p < 0.01, compared to miR-NC
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in Fig. 4e, miR-519d expressions were significantly
decreased in HIF1α overexpressing cells.
Because HIF1 complex acts as a transcriptional factor
through binding to the hypoxia-response element (HRE)
in various gene promoters, we checked whether the pro-
moter region of miR-519d contained any HRE. Indeed,
we have identified two HREs in the promoter region of
miR-519d (Fig. 5a). Further ChIP assays using anti-
HIF1α antibody showed direct binding of HIF1α to the
promoter of miR-519d in NPC cells, which can be
further enhanced by 24 h of 100 μM CoCl2 treatment
(Fig. 5b). We then cloned the promoter region of miR-
519d containing the two HREs (HRE-wt) or their
mutated version (HRE-mut) to the upstream promoter re-
gion of pGL3-enhancer plasmid. The results of luciferase
reporter assays showed decreased luciferase activity after
24 h of 100 μM CoCl2 treatment in cells transfected
with HRE-wt, whereas HRE-mut activity was unaffected
(Fig. 5c).
We next investigated whether the decrease in miR-
519d expression by OL treatment was mediated by
HIF1α. ChIP analysis showed that 24 h of 200 μM OL
treatment reduced the binding of HIF1α to the promoter
of miR-519d (Fig. 5d). The same OL treatment increased
the luciferase activity in cells transfected with HRE-wt,
but not HRE-mut (Fig. 5e). Taken together, our results
suggested OL treatment could result in direct binding of
HIF1α to the promoter region of miR-519d to induce its
upregulation.
Radiosensitizing effect of OL is mediated via the
HIF1α-miR-519d-PDRG1 pathway
The above data of our study confirmed OL treatment
could inhibit HIF1α-miR-519d-PDRG1 pathway, which
significantly enhanced radiosensitivity of NPC cells. We
then investigated whether the enhanced radiosensitizing
effect of OL was mediated by the HIF1α-miR-519d-
PDRG1 pathway. Stable HIF1α or PDRG1 overexpres-
sion was introduced in both HNE-1 and HONE-1 NPC
cells using a lentivirus based stable overexpression sys-
tem. As shown in Fig. 6a and b, overexpressing either
HIF1α or PDRG1 abolished the radiosensitizing effect of
OL treatment (200 μM OL for 24 h) in vitro, as indi-
cated by the colony formation assays. Furthermore, the
tumor sizes of the injected NPC cells with HIF1α or
PDRG1 overexpression were significantly larger than
those of the control cells, as shown in the xenograft
mice model (Fig. 6c and d). Of note, at the end of animal
studies on day 21, the xenograft tumors were harvested
and analyzed for expressions of HIF1α and PDRG1 in
the respective experimental groups, both of which were
still greatly elevated as expected (Fig. 6e and f).
At last, we examined whether miR-519d upregulation
was critical to the OL radiosensitizing effect. Stable NPC
cells expressing miR-519d inhibitor (anti-miR-519d)
were established using the MISSION Lenti miR-519d
Inhibitor kit. As shown in Fig. 7a and b, the radiosensi-
tizing effect of OL treatment (200 μM OL for 24 h) was
eliminated in the cells stably expressing miR-519d
Fig. 4 Hypoxia inhibits miR-519d expression in NPC cells. a, b NPC HNE-1 and HONE-1 were incubated for 24 h with media containing 0 or 100 μM
CoCl2, respectively, and expressions of HIF1α protein (a), as well as miR-519d (b), were examined. c to e) HNE-1 and HONE-1 cells expressing empty
vector and overexpressing HIF1α, respectively, were subjected to analyses of HIF1α mRNA (c) and protein (d), as well as miR-519d (e) levels.
Values were expressed as mean ± SD. * p < 0.05, ** p < 0.01, compared to control. # p < 0.05, ## p < 0.01, compared to empty vector
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inhibitor. Similarly, the in vivo xenograft model con-
firmed that inhibiting miR-519d significantly increased
tumor size after radiation, even with OL treatment
(Fig. 7c and d). Similarly, on day 21, level of miR-519d
were also examined in the harvested xenograft tumors,
and was indeed efficiently repressed by the MISSION
Lenti miR-519d Inhibitor kit, suggesting the long-lasting
effect of the stably inhibition (Fig. 7e). Together, our results
showed the HIF1α-miR-519d-PDRG1 pathway played im-
portant roles in the radiosensitizing effect induced by OL.
Discussion
OL is the main component of olive leaf extract, and has
been recognized as a healthy diet and a potential compo-
nent of medicine due to its phenolic contents [2].
Previous studies have identified OL as an anti-oxidative
[11, 13] and anti-inflammatory reagent [14]. Here, our
current study shows that OL exhibits a radiosensitizing
effect on NPC cells both in vivo and in vitro. Meanwhile,
our results show OL treatment can significantly reduce
the expression of HIF1α in NPC cells. Most importantly,
results in our study supports the working model where
OL increases radiosensitivity of NPC cells by inhibiting
the activity of the HIF1α-miR-519d-PDRG1 pathway
(Fig. 8).
HIF1α is the α subunit of hypoxia-inducible factor 1
(HIF1), which is an important transcription factor that
mediates adaptive responses to hypoxia. The activity of
HIF1 is mainly dependent on the regulation of HIF1α
[15]. Under normoxic conditions, HIF1α is hydroxylated
Fig. 5 OL upregulates miR-519d expression through the hypoxia response element (HRE) in its promoter region. a Promoter region of miR-519d
contains putative hypoxia response element (HRE). Wild type (HRE-wt, GCGTG) or mutated (HRE-mut, ATACA) HRE sites from miR-519d promoter
were cloned at the upstream of a luciferase reporter gene open reading frame (Luc ORF). b HNE-1 cells were incubated for 24 h with media containing
0 or 100 μM CoCl2, respectively, followed by ChIP assay using control IgG or HIF1α antibody (anti-HIF1α). c Luciferase activities of HRE-wt or HRE-mut
constructs were measured in HNE-1 cells treated as in (b). d HNE-1 cells were incubated for 24 h with media containing 0 or 200 μM of OL, respectively,
followed by ChIP assay using control IgG or HIF1α antibody (anti-HIF1α). e Luciferase activities of HRE-wt or HRE-mut constructs were
measured in HNE-1 cells treated as in (d). Values were expressed as mean ± SD. **p < 0.01, ***p < 0.001, ns1 not significant, compared to
control. #p < 0.05, ##p < 0.01, ns2 not significant, compared to 0 μM OL
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and ubiquitinated, resulting in its rapid degradation
[16, 17]. Whereas under hypoxic conditions, the deg-
radation of HIF1α is inhibited and a stable HIF1 complex
is formed. HIF1α activity is also found to be significantly
upregulated in various types of cancer, as a result of
genetic alterations and hypoxia within the tumor tissue.
The radiation and re-oxygenation of tumor tissue after
radiotherapy could induce the generation of reactive
oxygen species (ROS), leading to a stable HIF1 complex
[18]. In addition, two downstream targets of HIF1 that
can be upregulated by hypoxia, heme oxygenase-1 and
stanniocalcin 2, are found to be correlated with sensitivity
of NPC to radiotherapy [19, 20]. Our results are consistent
with another study, showing that OL treatment caused a
remarkable decrease in HIF1α protein in human colon
cancer cells [4]. HIF1 pathway activation leads to induced
angiogenesis and protection of tumor cells from radiation-
induced apoptosis in many types of cancer. Indeed, our
results show the radiosensitizing effect of OL is greatly
reduced in cancer cells overexpressing HIF1α, suggesting
the effect of OL is mediated via reducing HIF1α expres-
sion. Interestingly, as cellular HIF1α is mainly regulated
post-translationally at the protein level, either by hypoxia
or ROS [16, 17], it is intriguing that results in our current
study suggest OL regulation on HIF1α occurs at the
mRNA level. Further investigations are underway to reveal
the biological mechanisms underlying the observed regu-
lation of HIF1α mRNA by OL.
In the present study, we have investigated whether
miRNAs are involved in OL radiosensitizing effects.
Fig. 6 Enhanced radiosensitivity of NPC by OL can be reversed by HIF1α and PDRG1. a and b Using a lentivirus based stable overexpression
system, NPC cells HNE-1 (a) and HONE-1 (b) stably expressing empty vector, and overexpressing either HIF1α or PDRG1, respectively, were incubated
for 24 h with media containing 200 μM of OL, with 0 μM OL treatment as control, and then subjected to radiation dosage as indicated. c and e Growth
curve of HNE-1 (c) and HONE-1 (d) xenograft tumors expressing empty vector, and overexpressing either HIF1α or PDRG1, respectively, in mice after
OL treatment, with no OL administration as control (n = 10 each). e and f At the end of animal studies (day 21), xenograft tumors were harvested to
examine the expressions of HIF1α (e) and PDRG1 (f) following respective treatments as shown. Values were expressed as mean ± SD. * p < 0.05,
** p < 0.01, compared to 0 μM/no OL, OL + HIF1α and OL + PDRG1. # p < 0.05, ## p < 0.01, compared to OL + vector
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MiR-519d was previously shown to sensitize ovarian
cancer cells to cisplatin-induced cell death [21]. We then
studied whether miR-519d was a direct target of HIF1α
and involved in OL radiosensitizing effects. Our results
from ChIP and luciferase assays have showed HIF1α
directly binds to the promoter of miR-519d, which can
be attenuated by OL treatment. Further study shows the
radiosensitizing effect of OL is eliminated in the cells
stably expressing miR-519d inhibitor, suggesting miR-
519d is essential in the above process.
Fig. 7 Enhanced radiosensitivity of NPC by OL requires miR-519d. a and b Using the MISSION Lenti miR-519d Inhibitor kit, NPC HNE-1 (a) and
HONE-1 (b) stably expressing miR-519d inhibitor (anti-miR-519d) or control, respectively, were incubated for 24 h with media containing 200 μM
of OL, with 0 μM OL treatment as control, and then subjected to radiation dosage as indicated. c and e Growth curve of HNE-1 (c) and HONE-1
(d) xenograft tumors expressing miR-519d inhibitor (anti-miR-519d) or control, respectively, in mice after OL treatment, with no OL administration
as control (n = 10 each). e At the end of animal studies (day 21), xenograft tumors were harvested to examine the expressions of miR-519d following
respective treatments as shown. Values were expressed as mean ± SD. * p < 0.05, ** p < 0.01, compared to both 0 μM/no OL and OL + control
Fig. 8 Working model of OL action in promoting radiation sensitivity. OL decreases HIF1α expression, which in turn represses miR-519d expression.
miR-519d functions to directly target PDRG1 mRNA and inhibit its expression. PDRG1 is able to inhibit radiation sensitivity via the ATM-P53 axis.
The overall effect of OL in NPC is then to promote radiation sensitivity
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P53 and PDRG1 have been reported to be upregulated
in multiple cancers including lung, breast, stomach,
colon, rectum and ovary cancers [22]. PDRG1 expression
was found to be correlated with higher or more ad-
vanced tumor stages, suggesting it could play a role in
cancer progression [23]. A recently study also showed
PDRG1 could promote radiation-resistance in lung
cancer cells, which also involved the ATM-p53 signaling
pathway [24]. In our current study, we have found OL
treatment reduces both the expressions of PDRG1
mRNA and protein, which are necessary in the OL radi-
ation sensitizing effects. Furthermore, through miRanda
analysis, we have identified a potential binding sequence
of miR-519d in the 3′-UTR of PDRG1 mRNA. Lucifer-
ase reporter assay confirms PDRG1 is a direct target of
miR-519d. To our knowledge, this is the first study that
reveals the relationship between miR-519d and PDRG1.
Future studies are needed to investigate if other genes of
the DNA damage repair mechanism are also regulated
in a similar manner.
Conclusions
In conclusion, our study hereby demonstrates OL is a
radiation sensitizing agent of NPC cells both in vivo and
in vitro. OL treatment reduces the activity of HIF1α-
miR-519d-PDRG1 pathway (Fig. 8), which is essential to
the radiosensitizing effect of OL. Further studies are
warranted to optimize the regimen of OL treatment in
combination with radiation therapy, and to evaluate the
clinical effects of OL in NPC patients.
Abbreviations
HIF1: Hypoxia-inducible factor 1; NPC: Nasopharyngeal carcinoma;




This study was supported by grants from the General Program of the Key
Program of Nanjing Medical University (no. 2014NJMUZD034).
Availability of data and materials
Not applicable.
Authors’ contributions
TX collected and assembled the data; performed the statistical analysis;
DX conceived, designed the study and wrote the manuscript. Both
authors read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Consent for publication
Not applicable.
Ethics approval and consent to participate
All applicable international, national, and/or institutional guidelines for the
care and use of animals were followed.
Received: 21 October 2016 Accepted: 21 December 2016
References
1. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet‐Tieulent J, Jemal A. Global cancer
statistics, 2012. CA. 2015;65:87–108.
2. Omar SH. Oleuropein in olive and its pharmacological effects. Sci Pharm.
2010;78:133–54.
3. Hamdi HK, Castellon R. Oleuropein, a non-toxic olive iridoid, is an anti-
tumor agent and cytoskeleton disruptor. Biochem Biophys Res Commun.
2005;334:769–78.
4. Cárdeno A, Sánchez-Hidalgo M, Rosillo MA, de la Lastra CA. Oleuropein, a
secoiridoid derived from olive tree, inhibits the proliferation of human
colorectal cancer cell through downregulation of HIF-1α. Nutr Cancer.
2013;65:147–56.
5. Metheetrairut C, Slack FJ. MicroRNAs in the ionizing radiation response and
in radiotherapy. Curr Opin Genet Dev. 2013;23:12–9.
6. Kraemer A, Anastasov N, Angermeier M, Winkler K, Atkinson MJ, Moertl S.
MicroRNA-mediated processes are essential for the cellular radiation
response. Radiat Res. 2011;176:575–86.
7. Yan D, Ng WL, Zhang X, Wang P, Zhang Z, Mo Y-Y, et al. Targeting DNA-
PKcs and ATM with miR-101 sensitizes tumors to radiation. PLoS One.
2010;5:e11397.
8. Ng WL, Yan D, Zhang X, Mo Y-Y, Wang Y. Over-expression of miR-100 is
responsible for the low-expression of ATM in the human glioma cell line:
M059J. DNA Repair. 2010;9:1170–5.
9. Jiang P, Rao EY, Meng N, Zhao Y, Wang JJ. MicroRNA-17-92 significantly
enhances radioresistance in human mantle cell lymphoma cells. Radiat
Oncol. 2010;5:1.
10. Babar IA, Czochor J, Steinmetz A, Weidhaas JB, Glazer PM, Slack FJ.
Inhibition of hypoxia-induced miR-155 radiosensitizes hypoxic lung cancer
cells. Cancer Biol Ther. 2011;12:908–14.
11. Galli G, Caruso D. Biological activities and metabolic fate of olive oil
phenols. Eur J Lipid Sci Technol. 2002;104:677–84.
12. Enright AJ, John B, Gaul U, Tuschl T, Sander C, Marks DS. MicroRNA targets
in Drosophila. Genome Biol. 2003;5:R1. doi:10.1186/gb-2003-5-1-r1.
13. de la Puerta R, Domı́nguez MEM, Ruı́z-Gutı́errez V, Flavill JA, Hoult JRS.
Effects of virgin olive oil phenolics on scavenging of reactive nitrogen
species and upon nitrergic neurotransmission. Life Sci. 2001;69:1213–22.
14. Coni E, Di Benedetto R, Di Pasquale M, Masella R, Modesti D, Mattei R, et al.
Protective effect of oleuropein, an olive oil biophenol, on low density
lipoprotein oxidizability in rabbits. Lipids. 2000;35:45–54.
15. Wang GL, Jiang B-H, Rue EA, Semenza GL. Hypoxia-inducible factor 1 is a
basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension.
Proc Natl Acad Sci. 1995;92:5510–4.
16. Berra E, Roux D, Richard DE, Pouysségur J. Hypoxia‐inducible factor‐1α
(HIF‐1α) escapes O2‐driven proteasomal degradation irrespective of its
subcellular localization: nucleus or cytoplasm. EMBO Rep.
2001;2:615–20.
17. Jaakkola P, Mole DR, Tian Y-M, Wilson MI, Gielbert J, Gaskell SJ, et al.
Targeting of HIF-α to the von Hippel-Lindau ubiquitylation complex by
O2-regulated prolyl hydroxylation. Science. 2001;292:468–72.
18. Dewhirst MW, Cao Y, Moeller B. Cycling hypoxia and free radicals regulate
angiogenesis and radiotherapy response. Nat Rev Cancer. 2008;8:425–37.
19. Shi L, Fang J. Implication of heme oxygenase-1 in the sensitivity of
nasopharyngeal carcinomas to radiotherapy. J Exp Clin Cancer Res.
2008;27:13. doi:10.1186/1756-9966-27-13.
20. Lin S, Guo Q, Wen J, Li C, Lin J, Cui X, et al. Survival analyses correlate
stanniocalcin 2 overexpression to poor prognosis of nasopharyngeal
carcinomas. J Exp Clin Cancer Res. 2014;33:26. doi:10.1186/1756-9966-33-26.
21. Pang Y, Mao H, Shen L, Zhao Z, Liu R, Liu P. MiR-519d represses ovarian
cancer cell proliferation and enhances cisplatin-mediated cytotoxicity in
vitro by targeting XIAP. OncoTargets & Therapy. 2014;7:587–97.
22. Jiang L, Luo X, Shi J, Sun H, Sun Q, Sheikh MS, et al. PDRG1, a novel tumor
marker for multiple malignancies that is selectively regulated by genotoxic
stress. Cancer Biol Ther. 2011;11:567–73.
23. Wang J, Zhang X, Wang L, Yang Y, Dong Z, Wang H, et al. MicroRNA-214
suppresses oncogenesis and exerts impact on prognosis by targeting
PDRG1 in bladder cancer. PLoS One. 2015;10:e0118086.
24. Tao Z, Chen S, Mao G, Xia H, Huang H, Ma H. The PDRG1 is an oncogene in
lung cancer cells, promoting radioresistance via the ATM-P53 signaling
pathway. Biomed Pharmacother. 2016;83:1471–7.
Xu and Xiao Journal of Experimental & Clinical Cancer Research  (2017) 36:3 Page 10 of 10
